Peptidomimetic Therapeutics: Scientific Approaches and Opportunities

Qvit et al., Drug Discov Today (2016) - PMID: 27856346

Product(s) used in this publication:  Specialty Peptides


Natural endogenously occurring peptides exhibit desirable medicinal properties, but are often limited in application by rapid proteolysis and inadequate membrane permeability. However, editing naturally occurring peptide sequences to develop peptidomimetic analogs created a promising class of therapeutics that can augment or inhibit molecular interactions. Here, we discuss a variety of chemical modifications, including l to d isomerization, cyclization, and unnatural amino acid substitution, as well as design strategies, such as attachment to cell-penetrating peptides, which are used to develop peptidomimetics. We also provide examples of approved peptidomimetics and discuss several compounds in clinical trials.

Stay in touch and be the first to receive the latest news!